The proprietary extract of Nerium oleander has a much weaker argument for use to treat Covid-19 than hydroxychloroquine, which caught fire and Trump promoted after a similar non-peer-reviewed listing showing results in 20 patients, writes Kent Sepkowitz.
More Stories
Record Korean Cases; Trader’s Guide to Rollout: Virus Update
California Hits Record; Trader’s Guide to Rollout: Virus Update
AstraZeneca to Buy Alexion for $39 Billion in Rare-Disease Push